2023
DOI: 10.1177/03008916231153439
|View full text |Cite
|
Sign up to set email alerts
|

Duration of androgen deprivation with radiotherapy for high-risk or locally advanced prostate cancer: A network meta-analysis

Abstract: Objective: To evaluate various outcomes of different lengths of androgen deprivation therapy in high- and very-high-risk prostate cancer, we conducted a network meta-analysis of randomized trials. The treatment of high-risk PC comprises the use of radical radiotherapy associated with various durations of androgen deprivation therapy, with luteinizing hormone releasing hormone analogues initiated during or immediately before the beginning of radiation. Methods and Materials: This study followed the PRISMA exten… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 34 publications
0
1
0
Order By: Relevance
“…Several drugs are available that target androgen receptor signaling, including enzalutamide, apalutamide, and darolutamide. These drugs have been shown to improve survival in patients with metastatic prostate cancer and are being studied in men with locally advanced disease, particularly in combination with radiation therapy [ 40 , 41 ], although the longer term effects on changes to muscle mass and adiposity are unknown [ 42 ].…”
Section: Resultsmentioning
confidence: 99%
“…Several drugs are available that target androgen receptor signaling, including enzalutamide, apalutamide, and darolutamide. These drugs have been shown to improve survival in patients with metastatic prostate cancer and are being studied in men with locally advanced disease, particularly in combination with radiation therapy [ 40 , 41 ], although the longer term effects on changes to muscle mass and adiposity are unknown [ 42 ].…”
Section: Resultsmentioning
confidence: 99%